 |
The Journal of Neuroscience, February 20, 2008, 28(8):1988-1993; doi:10.1523/JNEUROSCI.5323-07.2008
Previous Article
Brief Communications
The Good, the Bad, and the Cell Type-Specific Roles of Hypoxia Inducible Factor-1 in Neurons and Astrocytes
Grace Vangeison,1
Dan Carr,1
Howard J. Federoff,2 and
David A. Rempe1
1Department of Neurology, Center for Neural Development and Disease, and Interdepartmental Graduate Program in Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, and 2Georgetown University Medical Center, Washington, DC 20057
Correspondence should be addressed to David A. Rempe, Center for Neural Development and Disease, Box 645, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642. Email: david_rempe{at}urmc.rochester.edu
Hypoxia inducible factor-1 (HIF-1 ) is a key regulator of oxygen homeostasis, because it is responsible for the regulation of genes involved in glycolysis, erythropoiesis, angiogenesis, and apoptosis. In the CNS, HIF-1 is stabilized by insults associated with hypoxia and ischemia. Because its many target genes mediate both adaptive and pathological processes, the role of HIF-1 in neuronal survival is debated. Although neuronal HIF-1 function has been the topic of several studies, the role of HIF-1 function in astrocytes has received much less attention. To characterize the role of HIF-1 in neurons and astrocytes, we induced loss of HIF-1 function specifically in neurons, astrocytes, or both cell types in neuron/astrocyte cocultures exposed to hypoxia. Although loss of HIF-1 function in neurons reduced neuronal viability during hypoxia, selective loss of HIF-1 function in astrocytes markedly protected neurons from hypoxic-induced neuronal death. Although the pathological processes induced by HIF-1 in astrocytes remain to be defined, induction of inducible nitric oxide synthase likely contributes to the pathological process. This study delineates, for the first time, a cell type-specific action for HIF-1 within astrocytes and neurons.
Key words: HIF-1; astrocyte; neuron; hypoxia; ischemia; neurotoxicity
Received Aug. 20, 2007;
revised Jan. 11, 2008;
accepted Jan. 12, 2008.
Correspondence should be addressed to David A. Rempe, Center for Neural Development and Disease, Box 645, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642. Email: david_rempe{at}urmc.rochester.edu
This article has been cited by other articles:

|
 |

|
 |
 
Y. Li, S. Lim, D. Hoffman, P. Aspenstrom, H. J. Federoff, and D. A. Rempe
HUMMR, a hypoxia- and HIF-1{alpha}-inducible protein, alters mitochondrial distribution and transport
J. Cell Biol.,
June 15, 2009;
185(6):
1065 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lomb, L. A. Desouza, J. L. Franklin, and R. S. Freeman
Prolyl Hydroxylase Inhibitors Depend on Extracellular Glucose and Hypoxia-Inducible Factor (HIF)-2{alpha} to Inhibit Cell Death Caused by Nerve Growth Factor (NGF) Deprivation: Evidence that HIF-2{alpha} Has a Role in NGF-Promoted Survival of Sympathetic Neurons
Mol. Pharmacol.,
May 1, 2009;
75(5):
1198 - 1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Y. Chen and M.-S. Chang
IL-20 Is Regulated by Hypoxia-Inducible Factor and Up-Regulated after Experimental Ischemic Stroke
J. Immunol.,
April 15, 2009;
182(8):
5003 - 5012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. T. Hare, A. K. Y. Tsui, A. T. McLaren, T. E. Ragoonanan, J. Yu, and C. D. Mazer
Anemia and Cerebral Outcomes: Many Questions, Fewer Answers
Anesth. Analg.,
October 1, 2008;
107(4):
1356 - 1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Qutub and A. S. Popel
Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1{alpha} Differentially in Cancer and Ischemia
Mol. Cell. Biol.,
August 15, 2008;
28(16):
5106 - 5119.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|